Development of an Agent‐Based Model to Investigate Durability of Factor <scp>IX</scp> Activity in Hemophilia B Patients Treated With Etranacogene Dezaparvovec

Yuezhe Li, Partha Nandy, Eric Jordie, Timothy Knab, Karsten Peppel, Daniel C. Kirouac, A. Katharina Wilkins, Silpa Nuthalapati

Open source

DOI: 10.1002/psp4.70286
Published: 2026-06-20
Container: CPT: Pharmacometrics & Systems Pharmacology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/psp4.70286,
  title = {Development of an Agent‐Based Model to Investigate Durability of Factor
                    <scp>IX</scp>
                    Activity in Hemophilia B Patients Treated With Etranacogene Dezaparvovec},
  author = {Yuezhe Li and Partha Nandy and Eric Jordie and Timothy Knab and Karsten Peppel and Daniel C. Kirouac and A. Katharina Wilkins and Silpa Nuthalapati},
  year = {2026},
  journal = {CPT: Pharmacometrics \&amp; Systems Pharmacology},
  doi = {10.1002/psp4.70286},
  url = {https://doi.org/10.1002/psp4.70286}
}

RIS

TY  - JOUR
TI  - Development of an Agent‐Based Model to Investigate Durability of Factor
                    <scp>IX</scp>
                    Activity in Hemophilia B Patients Treated With Etranacogene Dezaparvovec
AU  - Yuezhe Li
AU  - Partha Nandy
AU  - Eric Jordie
AU  - Timothy Knab
AU  - Karsten Peppel
AU  - Daniel C. Kirouac
AU  - A. Katharina Wilkins
AU  - Silpa Nuthalapati
PY  - 2026
JO  - CPT: Pharmacometrics &amp; Systems Pharmacology
DO  - 10.1002/psp4.70286
UR  - https://doi.org/10.1002/psp4.70286
ER  -

APA

Li, Y., Nandy, P., Jordie, E., Knab, T., Peppel, K., Kirouac, D. C., Wilkins, A. K., & Nuthalapati, S. (2026). Development of an Agent‐Based Model to Investigate Durability of Factor <scp>IX</scp> Activity in Hemophilia B Patients Treated With Etranacogene Dezaparvovec. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.70286

Source records

crossref · retrieved 2026-09-25T08:25:02.023Z